These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 12784879)

  • 1. Imaging glioblastoma multiforme.
    Nelson SJ; Cha S
    Cancer J; 2003; 9(2):134-45. PubMed ID: 12784879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Robust texture features for response monitoring of glioblastoma multiforme on T1-weighted and T2-FLAIR MR images: a preliminary investigation in terms of identification and segmentation.
    Assefa D; Keller H; Ménard C; Laperriere N; Ferrari RJ; Yeung I
    Med Phys; 2010 Apr; 37(4):1722-36. PubMed ID: 20443493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Image-driven modeling of the proliferation and necrosis of glioblastoma multiforme.
    Patel V; Hathout L
    Theor Biol Med Model; 2017 May; 14(1):10. PubMed ID: 28464925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Radiomics and Metabolic Tumor Volumes in Radiation Treatment of Glioblastoma Multiforme.
    Lopez CJ; Nagornaya N; Parra NA; Kwon D; Ishkanian F; Markoe AM; Maudsley A; Stoyanova R
    Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):586-595. PubMed ID: 28011044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative Clinical Imaging Methods for Monitoring Intratumoral Evolution.
    Kim JY; Gatenby RA
    Methods Mol Biol; 2017; 1513():61-81. PubMed ID: 27807831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serial proton magnetic resonance spectroscopy imaging of glioblastoma multiforme after brachytherapy.
    Wald LL; Nelson SJ; Day MR; Noworolski SE; Henry RG; Huhn SL; Chang S; Prados MD; Sneed PK; Larson DA; Wara WM; McDermott M; Dillon WP; Gutin PH; Vigneron DB
    J Neurosurg; 1997 Oct; 87(4):525-34. PubMed ID: 9322843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation between vasogenic-edema versus tumor-infiltrative area in patients with glioblastoma during bevacizumab therapy: a longitudinal MRI study.
    Artzi M; Bokstein F; Blumenthal DT; Aizenstein O; Liberman G; Corn BW; Ben Bashat D
    Eur J Radiol; 2014 Jul; 83(7):1250-1256. PubMed ID: 24809637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of IVIM-DWI and 3D-ASL for differentiating true progression from pseudoprogression of Glioblastoma multiforme after concurrent chemoradiotherapy: study protocol of a prospective diagnostic trial.
    Liu ZC; Yan LF; Hu YC; Sun YZ; Tian Q; Nan HY; Yu Y; Sun Q; Wang W; Cui GB
    BMC Med Imaging; 2017 Feb; 17(1):10. PubMed ID: 28143434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential role of advanced MRI techniques for the peritumoural region in differentiating glioblastoma multiforme and solitary metastatic lesions.
    Lee EJ; Ahn KJ; Lee EK; Lee YS; Kim DB
    Clin Radiol; 2013 Dec; 68(12):e689-97. PubMed ID: 23969153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of unsupervised classification methods for brain tumor segmentation using multi-parametric MRI.
    Sauwen N; Acou M; Van Cauter S; Sima DM; Veraart J; Maes F; Himmelreich U; Achten E; Van Huffel S
    Neuroimage Clin; 2016; 12():753-764. PubMed ID: 27812502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of MR markers that predict survival in patients with newly diagnosed GBM prior to adjuvant therapy.
    Saraswathy S; Crawford FW; Lamborn KR; Pirzkall A; Chang S; Cha S; Nelson SJ
    J Neurooncol; 2009 Jan; 91(1):69-81. PubMed ID: 18810326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CXCR4 expression is elevated in glioblastoma multiforme and correlates with an increase in intensity and extent of peritumoral T2-weighted magnetic resonance imaging signal abnormalities.
    Stevenson CB; Ehtesham M; McMillan KM; Valadez JG; Edgeworth ML; Price RR; Abel TW; Mapara KY; Thompson RC
    Neurosurgery; 2008 Sep; 63(3):560-9; discussion 569-70. PubMed ID: 18812968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiologic characterisation of glioblastoma multiforme using MRI-based hypoxia mapping, chemical shift imaging, perfusion and diffusion maps.
    McMillan KM; Rogers BP; Field AS; Laird AR; Fine JP; Meyerand ME
    J Clin Neurosci; 2006 Oct; 13(8):811-7. PubMed ID: 16997706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Glioblastoma multiforme... with multifocal presentation].
    Sousa G; Rocha A; Alfaiate T; Carvalho T; Veiga e Moura A; Ferreira MR
    Acta Med Port; 2002; 15(4):321-4. PubMed ID: 12525027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphomas and glioblastomas: differences in the apparent diffusion coefficient evaluated with high b-value diffusion-weighted magnetic resonance imaging at 3T.
    Doskaliyev A; Yamasaki F; Ohtaki M; Kajiwara Y; Takeshima Y; Watanabe Y; Takayasu T; Amatya VJ; Akiyama Y; Sugiyama K; Kurisu K
    Eur J Radiol; 2012 Feb; 81(2):339-44. PubMed ID: 21129872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unusual magnetic resonance imaging appearance of multiple cystic lesions in glioblastoma multiforme.
    Lyons M
    Turk Neurosurg; 2013; 23(1):95-7. PubMed ID: 23344874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MR imaging of glioblastoma in children: usefulness of diffusion/perfusion-weighted MRI and MR spectroscopy.
    Chang YW; Yoon HK; Shin HJ; Roh HG; Cho JM
    Pediatr Radiol; 2003 Dec; 33(12):836-42. PubMed ID: 14564423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of the functional imaging modalities in radiation therapy treatment planning in patients with glioblastoma].
    Dhermain F; Ducreux D; Bidault F; Bruna A; Parker F; Roujeau T; Beaudre A; Armand JP; Haie-Meder C
    Bull Cancer; 2005 Apr; 92(4):333-42. PubMed ID: 15888390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normalized Apparent Diffusion Coefficient in the Prognostication of Patients with Glioblastoma Multiforme.
    Shankar JJ; Bata A; Ritchie K; Hebb A; Walling S
    Can J Neurol Sci; 2016 Jan; 43(1):127-33. PubMed ID: 26786643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of microheterogeneity in glioblastoma multiforme with ex vivo high-resolution magic-angle spinning (HRMAS) proton magnetic resonance spectroscopy.
    Cheng LL; Anthony DC; Comite AR; Black PM; Tzika AA; Gonzalez RG
    Neuro Oncol; 2000 Apr; 2(2):87-95. PubMed ID: 11303625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.